Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IST:ANGEN's PS Ratio is ranked better than 50.56% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.87
vs IST:ANGEN: 2.75
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve PS Ratio Related Terms
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve PS Ratio Chart
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve PS Ratio vs Medical Devices & Instruments Industry
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Share Price of today is ₺9.40. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺3.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) has a PS Ratio of 2.75 as of Jul. 31, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve and its competitors. This is 58% below median its historical median of 6.55. Over the past decade, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's PS Ratio has ranged from 2.75 to 14.42. According to the industry distribution chart, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve ranks #397 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 49.4%.
Is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's PS Ratio too high?
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's current PS Ratio of 2.75 is 58% below median its 10-year median of 6.55. Over the past 10 years, this metric has ranged from a low of 2.75 to a high of 14.42. The Medical Devices & Instruments industry median PS Ratio is 2.87. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's value of 2.75 is 4.2% below this industry median. Based on the distribution chart, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve ranks #397 out of 803 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve has a GF Scoreâ„¢ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve ranks #397 out of 803 companies for PS Ratio. This puts Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve in the upper half of its industry. The industry median PS Ratio is 2.87. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's value of 2.75 is 4.2% below this benchmark. Historically, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's own PS Ratio has ranged from 2.75 to 14.42 over the past decade. While the company's 10-year median is 6.55 vs. the industry median of 2.87, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.87, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's current PS Ratio of 2.75 is 4.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's current PS Ratio is 2.75, which is 58% below median its own 10-year median of 6.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve stock overvalued right now?
Based on GuruFocus' analysis, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) is currently considered Possible Value Trap. The stock's GF Value™ is ₺18.63, compared to a current price of ₺9.40 — trading 49.5% below its estimated fair value. The current PS Ratio is 2.75, which is 58% below median its 10-year median of 6.55 and 4.2% below the Medical Devices & Instruments industry median of 2.87. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN), the current PS Ratio is 2.75 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve (IST:ANGEN) Overvalued in 2026?
Based on GuruFocus' analysis, Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve stock appears to be undervalued.
The current stock price of ₺9.40 is trading 49.5% below its estimated GF Value™ of ₺18.63.
GuruFocus considers Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve to be Possible Value Trap.
Key valuation signals for IST:ANGEN:
PS Ratio: 2.75 (58% below median its 10-year median of 6.55)
GF Value™: ₺18.63 vs. price of ₺9.40 (49.5% below fair value)
Industry Position: 4.2% below the Medical Devices & Instruments median (#397 of 803)
No single metric tells the full story. See the IST:ANGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS is an international biotechnology company. It is engaged in designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It also manufactures NA Extraction kits, Microbiology kits, Genetic Disorders kits, Panel kits, Sequencing kits, Food Testing kits.
55GF Score
Get the complete analysis for IST:ANGEN
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ANGEN has been successfully added to your 
